Key Dates

Related Announcements

NOT-OD-23-006 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2023 Councils

PA-22-255 - AHRQ Mentored Research Scientist Career Development Award (K01)

RFA-HS-22-010 - AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32)

NOT-OD-22-113 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2023 Councils.

RFA-HS-22-008 - Diagnostic Centers of Excellence: Partnerships to Improve Diagnostic Safety and Quality (R18)

RFA-HS-22-001 - Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18).

PA-22-051 - AHRQ Mentored Career Enhancement Awards for Established Investigators in Patient-Centered Outcome Research (K18)

PA-22-050 - AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08)

PA-22-049 - AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01)

NOT-OD-21-179 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2022 Council

NOT-OD-20-163 - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic

NOT-OD-20-123 - Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic

NOT-OD-19-083 - Update to the NIH/AHRQ/NIOSH Policy on Post-Submission Materials
PA-22-168 - AHRQ Administrative Supplements for Grants in Health Services Research

Issued by

Office of The Director, National Institutes of Health (OD)

Purpose

This Notice extends the special exception for preliminary data as post-submission material (see NOT-OD-20-123; NOT-OD-20-163; and NOT-OD-20-179) to applications submitted for the January 2022 Council round.

For applications submitted for the January 2022 Council (beginning with applications submitted for the May 25, 2021 due date for Fall 2021 review meetings), the NIH, AHRQ, and NIOSH will accept a one-page update with preliminary data as post-submission materials for applications submitted under all activity codes, ONLY if the Funding Opportunity Announcement (FOA) used for submission allowed preliminary data in the application. One page of preliminary data will be accepted for single component applications or for each component of a multi-component application.

The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting or as stipulated in the FOA. Because applications for emergency competitive revisions and urgent competitive revisions undergo expedited review, post-submission materials will not be accepted for those applications.

All other materials listed in NOT-OD-19-083 as acceptable post-submission materials will continue to be accepted if submitted 30 days before the study section meeting or as stipulated in the FOA. Instructions for submission are included in NOT-OD-19-083.

Inquiries

Please direct all inquiries to:

Sally A. Amero, Ph.D.
NIH Review Policy Officer
Email: ReviewPolicyOfficer@mail.nih.gov

Francis D. Chesley, Jr., M.D.
Agency for Healthcare Research and Quality
Telephone: 301-427-1521
Email: Francis.Chesley@ahrq.hhs.gov

Steve Dearwent, Ph.D.
Centers for Disease Control and Prevention
Telephone: 404-498-6382
Email:Sed7@cdc.gov

Michael Goldcamp, Ph.D.
Centers for Disease Control and Prevention
Telephone: 304-285-5951
Email: ehg8@cdc.gov